Cannabis Stock Investors Optimistic After House Votes to Decriminalize Marijuana
Written by
Yaël Bizouati-Kennedy
Edited by
Nicholas Morine
Commitment to Our Readers
GOBankingRates' editorial team is committed to bringing you unbiased reviews and information. We use data-driven methodologies to evaluate financial products and services - our reviews and ratings are not influenced by advertisers. You can read more about our editorial guidelines and our products and services review methodology.
20 Years
Helping You Live Richer
Reviewed
by Experts
Trusted by
Millions of Readers
The House of Representatives passed the “Marijuana Opportunity Act” (MORE Act) on April 1, a bill which would decriminalize marijuana at the federal level. News of a potential federal decriminalization triggered renewed investor optimism. The bill now goes to the Senate.
The House voted 220-204 to pass the bill, mainly along party lines. Three Republicans sided with the Democrats in favor of the measure, while two Democrats voted against it, Barron’s reported.
The Street reports that among the beneficiaries of potential federal decriminalization is Tilray Brands, which climbed more than 500% in 2018 when cannabis was legalized in Canada. Tilray was, however, mostly flat in pre-market trading April 4, up 0.13%.
And according to Seeking Alpha, the legislative win marks another potential catalyst for the beaten-down cannabis sector at a time when both ETFMG Alternative Harvest ETF and AdvisorShares Pure US Cannabis ETF are trading more than 50% lower than the year-ago level. They were both up 0.7% in pre-market trading Monday April 4.
“I applaud the House for passing the MORE Act and bringing us one step closer to decriminalizing cannabis nationally, a critical and urgent issue of equity,” Washington Governor Jay Inslee tweeted April 1.
Federal decriminalization could have major ramifications for cannabis companies. Said companies would no longer be subject to a section of the U.S. internal revenue code that prohibits taxpayers from deducting business expenses associated with controlled substances, Pedro Palandrani — director of research at Global X ETFs — told Barron’s.
In addition, decriminalization (and potential, eventual legalization) could unlock access to basic financing options, like loans and capital raising on U.S. exchanges, per Palandrani.
“Furthermore, the possible establishment of cannabis as a commodity with futures contracts and more relaxed regulations regarding land use for cannabis cultivation could also assist developing supply chain dynamics,” Palandrani concluded.
The bill noted that 37 states, the District of Columbia, Puerto Rico, Guam and the U.S. Virgin Islands have adopted laws allowing legal access to cannabis. Also, 15 states, the District of Columbia, the Commonwealth of the Northern Mariana Islands and Guam have adopted laws legalizing cannabis for adult recreational use. In addition, legal cannabis sales totaled $20 billion in 2020 and are projected to reach $40.5 billion by 2025, per the bill’s text.
